Comparing the characteristics of patients on TNFα inhibitors with those on other treatments, the only differences found in terms of cardiovascular risk factors were that the former had lower rates of hypertension and lower levels of homocysteine (Supplementary Table S1). Here, TNF is linked to Hypertension.